The cost of prescription drugs in the United States has been a topic of concern for many years. Various proposals and acts have been put forth over the years to address this issue. Fortunately, as a result of the Inflation Reduction Act of 2022, Medicare beneficiaries may soon gain more affordable access to popular-yet-expensive medications.
Click to read about the first 10 drugs up for price negotiations in this Forbes article.
Comments